Alto Neuroscience (ANRO) Earnings Date, Estimates & Call Transcripts $4.27 -0.21 (-4.69%) (As of 11/20/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Alto Neuroscience Latest Earnings SummaryUpcoming Earnings DateMar. 20EstimatedActual EPS (Nov. 12) -$0.62 Beat By $0.05 Consensus EPS (Nov. 12) -$0.67 Alto Neuroscience issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.62, which topped the consensus estimate of -$0.67 by $0.05. With a trailing EPS of $0.00, Alto Neuroscience's earnings are expected to grow next year, from ($2.60) to ($2.58) per share. ANRO Upcoming EarningsAlto Neuroscience's next earnings date is estimated for Thursday, March 20, 2025, based off prior year's reporting schedules. Get Alto Neuroscience Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alto Neuroscience and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataANRO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANRO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Alto Neuroscience Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241-$0.82-$0.82-$0.82Q3 20242-$0.64-$0.61-$0.63Q4 20242-$0.70-$0.66-$0.6820245-$2.16-$2.09-$2.13Q1 20252-$0.67-$0.59-$0.63Q2 20252-$0.69-$0.61-$0.65Q3 20252-$0.70-$0.62-$0.66Q4 20252-$0.72-$0.65-$0.69FY 20258($2.78)($2.47)($2.63) Alto Neuroscience Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/20/2025(Estimated)------- 11/12/2024--$0.67-$0.62+$0.05-$0.62--8/13/2024Q2 2024-$0.67-$0.60+$0.07-$0.60-- 5/14/2024Q1 2024-$0.46-$0.76 -$0.30-$0.76-- Alto Neuroscience Earnings - Frequently Asked Questions When is Alto Neuroscience's earnings date? Alto Neuroscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates. Learn more on ANRO's earnings history. Did Alto Neuroscience beat their earnings estimates last quarter? In the previous quarter, Alto Neuroscience (NYSE:ANRO) reported ($0.62) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.67) by $0.05. Learn more on analysts' earnings estimate vs. ANRO's actual earnings. How much revenue does Alto Neuroscience generate each year? Alto Neuroscience (NYSE:ANRO) has a recorded annual revenue of $210,000.00. How much profit does Alto Neuroscience generate each year? Alto Neuroscience (NYSE:ANRO) has a recorded net income of -$36.31 million. ANRO has generated $0.00 earnings per share over the last four quarters. What is Alto Neuroscience's EPS forecast for next year? Alto Neuroscience's earnings are expected to grow from ($2.60) per share to ($2.58) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Alumis Earnings Xeris Biopharma Earnings SIGA Technologies Earnings Cartesian Therapeutics Earnings Korro Bio Earnings Tango Therapeutics Earnings Aura Biosciences Earnings Foghorn Therapeutics Earnings Taysha Gene Therapies Earnings Aquestive Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. This page (NYSE:ANRO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANRO Stock Alerts